Medication use pattern and predictors of optimal therapy at discharge in 8176 patients with acute coronary syndrome from 6 Middle Eastern countries: Data from the gulf registry of acute coronary events

Angiology

Volumn 62, Issue 6, 2011, Pages 447-454

  Al Zakwani, Ibrahim ^a,b   Zubaid, Mohammad ^c   Panduranga, Prashanth ^d   Rashed, Wafa ^e   Sulaiman, Kadhim ^d   Almahmeed, Wael ^f   Al Motarreb, Ahmed ^g   Al Suwaidi, Jassim ^h   Amin, Haitham ⁱ  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b Gulf Health Research   (Oman)

^c KUWAIT UNIVERSITY   (Kuwait)

^d ROYAL HOSPITAL   (Oman)

^e MUBARAK AL KABEER HOSPITAL   (Kuwait)

^f SHEIKH KHALIFA MEDICAL CITY   (United Arab Emirates)

^g Al Thawra Hospital   (Yemen)

^h HAMAD MEDICAL CORPORATION   (Qatar)

ⁱ BAHRAIN DEFENCE FORCE HOSPITAL   (Bahrain)

Author keywords

acute coronary syndrome; antihypertensive agents; antiplatelet drugs; coronary heart disease; evidence based medications; Middle East; statin; treatment

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID; NITRATE;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BAHRAIN; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; COMBINATION CHEMOTHERAPY; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE REGISTRY; DRUG USE; EVIDENCE BASED MEDICINE; FEMALE; HEART ARREST; HEART CATHETERIZATION; HOSPITAL DISCHARGE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; KUWAIT; MAJOR CLINICAL STUDY; MALE; OMAN; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PRESCRIPTION; QATAR; RECURRENT DISEASE; SCORING SYSTEM; SENESCENCE; SEX DIFFERENCE; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; UNITED ARAB EMIRATES; UNIVERSITY HOSPITAL; YEMEN;

ACUTE CORONARY SYNDROME; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST; PATIENT DISCHARGE; REGISTRIES;

EID: 79960958649     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319710394163     Document Type: Article

References (37)

1. Ramahi TM Cardiovascular disease in the Asia Middle East region: global trends and local implications. Asia Pac J Public Health. 2010 ; 22 (3suppl). 83S - 89S.
2. Eagle KA, Montoye CK, Riba AL, et al. Guideline-based standardized care is associated with substantially lower mortality in Medicare patients with acute myocardial infarction: the American College of Cardiology's Guidelines Applied in Practice (GAP) Projects in Michigan. J Am Coll Cardiol. 2005 ; 46 (7). 1242-1248. (Pubitemid 41615544)
3. Hiratzka LF, Eagle KA, Liang L., Fonarow GC, LaBresh KA, Peterson ED Get With the Guidelines Steering Committee. Atherosclerosis secondary prevention performance measures after coronary bypass graft surgery compared with percutaneous catheter intervention and nonintervention patients in the Get With the Guidelines database. Circulation. 2007 ; 116 (11suppl). 1207-1212.
4. Melloni C., Newby LK Risk factor management after acute coronary syndromes. Heart. 2009 ; 95 (17). 1382-1384.
5. Smith SC Jr, Allen J., Blair SN, et al. AHA/ACC; National Heart, Lung, and Blood Institute. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006 ; 113 (19). 2363-2372. (Pubitemid 43947981)
6. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/ non ST-elevation myocardial infarction: a report of the American College of Cardiology/American heart association task force on practice guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non- ST-elevation myocardial infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation. 2007 ; 116 (17). e148 - e304.
7. Kushner FG, Hand M., Smith SC Jr, et al. 2009 Focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009 ; 120 (22). 2271-2306.
8. Krumholz HM, Anderson JL, Bachelder BL, et al. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to develop performance measures for ST-elevation and non-ST-elevation myocardial infarction): developed in collaboration with the American Academy of Family Physicians and the American College of Emergency Physicians: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine. Circulation. 2008 ; 118 (24). 2596-2648.
9. Mukherjee D., Fang J., Chetcuti S., Moscucci M., Kline-Rogers E., Eagle KA Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation. 2004 ; 109 (6). 745-749. (Pubitemid 38222894)
10. Danchin N., Cambou JP, Hanania G., et al. USIC 2000 investigators. Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry. Am Heart J. 2005 ; 150 (6). 1147-1153. (Pubitemid 41773515)
11. Yan AT, Yan RT, Tan M., et al. Canadian ACS Registries Investigators. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome. Am Heart J. 2007 ; 154 (6). 1108-1115. (Pubitemid 350123528)
12. Bi Y., Gao R., Patel A., et al. CPACS Investigators. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study. Am Heart J. 2009 ; 157 (3). 509-516.
13. LaBresh KA, Ellrodt AG, Gliklich R., Liljestrand J., Peto R. Get with the guidelines for cardiovascular secondary prevention: pilot results. Arch Intern Med. 2004 ; 164 (2). 203-209. (Pubitemid 38140408)
14. Brilakis ES, Hernandez AF, Dai D., et al. Quality of care for acute coronary syndrome patients with known atherosclerotic disease: results from the Get With the Guidelines Program. Circulation. 2009 ; 120 (7). 560-567.
15. Zubaid M., Rashed WA, Saad H., et al. Kuwait acute coronary syndromes registry: baseline characteristics, management practices and in-hospital outcomes of patients hospitalized with acute coronary syndromes in Kuwait. Med Princ Pract. 2007 ; 16 (6). 407-412. (Pubitemid 47538119)
16. Zubaid M., Rashed WA, Al- Khaja N., et al. Clinical presentation and outcomes of acute coronary syndromes in the gulf registry of acute coronary events (Gulf RACE). Saudi Med J. 2008 ; 29 (2). 251-255. (Pubitemid 351385128)
17. Zubaid M., Rashed WA, Almahmeed W., et al. Management and outcomes of Middle Eastern patients admitted with acute coronary syndromes in the Gulf Registry of Acute Coronary Events (Gulf RACE). Acta Cardiol. 2009 ; 64 (4). 439-446.
18. Cannon CP, Battler A., Brindis RG, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol. 2001 ; 38 (7). 2114-2130. (Pubitemid 33116592)
19. Lemeshow S., Hosmer DWJ. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol. 1982 ; 115 (1). 92-106. (Pubitemid 12205725)
20. Bramlage P., Messer C., Bitterlich N., et al. The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction. Heart. 2010 ; 96 (8). 604-609.
21. Lee JH, Yang DH, Park HS, et al. Korea Acute Myocardial Infarction Registry Investigators. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value. Am Heart J. 2010 ; 159 (6). 1012-1019.
22. Mandelzweig L., Battler A., Boyko V., et al, on behalf of the Euro Heart Survey Investigators. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J. 2006 ; 27 (19). 2285-2293. (Pubitemid 44453571)
23. Mehta RH, Roe MT, Chen AY, et al. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative. Arch Intern Med. 2006 ; 166 (18). 2027-2034. (Pubitemid 44537186)
24. ACTION Registry-GWTG. National Cardiovascular Data Registry Web site. http://www.ncdr.com/WebNCDR/Action/default.aspx. Accessed September 24, 2010.
25. Goodman SG, Huang W., Yan AT, et al. Expanded Global Registry of Acute Coronary Events (GRACE2) Investigators. The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. Am Heart J. 2009 ; 158 (2). 193-201.e1-5.
26. Austin PC, Tu JV, Ko DT, Alter DA Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction. CMAJ. 2008 ; 179 (9). 901-908.
27. Granger CB, Steg PG, Peterson E., et al. GRACE Investigators. Medication performance measures and mortality following acute coronary syndromes. Am J Med. 2005 ; 118 (8). 858-865. (Pubitemid 41097463)
28. Salomaa V., Pääkkönen R., Hämäläinen H., Niemi M., Klaukka T. Use of secondary preventive medications after the first attack of acute coronary syndrome. Eur J Cardiovasc Prev Rehabil. 2007 ; 14 (3). 386-391. (Pubitemid 46945561)
29. Roe MT, Peterson ED, Newby LK, et al. The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes. Am Heart J. 2006 ; 151 (6). 1205-1213. (Pubitemid 44172870)
30. Panduranga P., Sulaiman K., Al-Zakwani I., et al. Utilization and determinants of in-hospital cardiac catheterization in patients with acute coronary syndrome from the Middle East. Angiology. 2010 ; 61 (8). 744-750.
31. Goldberg RJ, Spencer FA, Steg PG, et al. Global Registry of Acute Coronary Events Investigators. Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: a multinational perspective. Arch Intern Med. 2007 ; 167 (16). 1766-1773. (Pubitemid 47403065)
32. Xavier D., Pais P., Devereaux PJ, et al, CREATE registry investigators. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet. 2008 ; 371 (9622). 1435-1442. (Pubitemid 351601890)
33. Burwen DR, Galusha DH, Lewis JM, et al. National and state trends in quality of care for acute myocardial infarction between 1994-1995 and 1998-1999: the Medicare health care quality improvement program. Arch Intern Med. 2003 ; 163 (12). 1430-1439. (Pubitemid 36758915)
34. Gislason GH, Rasmussen JN, Abildstrøm SZ, et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J. 2006 ; 27 (10). 1153-1158.
35. Bagnall AJ, Yan AT, Yan RT, et al, Canadian Acute Coronary Syndromes Registry II Investigators. Optimal medical therapy for non-ST-segment-elevation acute coronary syndromes: exploring why physicians do not prescribe evidence-based treatment and why patients discontinue medications after discharge. Circ Cardiovasc Qual Outcomes. 2010 ; 3 (5). 530-537.
36. Lewis WR, Ellrodt AG, Peterson E., et al. Trends in the use of evidence-based treatments for coronary artery disease among women and the elderly: findings from the get with the guidelines quality-improvement program. Circ Cardiovasc Qual Outcomes. 2009 ; 2 (6). 633-641.
37. Yusuf S., Pais P., Afzal R., et al. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet. 2009 ; 373 (9672). 1341-1351.